Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Multi-scale Modeling in Clinical Oncology: Opportunities and Barriers to Success.

Yankeelov TE, An G, Saut O, Luebeck EG, Popel AS, Ribba B, Vicini P, Zhou X, Weis JA, Ye K, Genin GM.

Ann Biomed Eng. 2016 Sep;44(9):2626-41. doi: 10.1007/s10439-016-1691-6.

PMID:
27384942
2.

Comprehensive review of epidemiological and animal studies on the potential carcinogenic effects of nicotine per se.

Haussmann HJ, Fariss MW.

Crit Rev Toxicol. 2016 Sep;46(8):701-34. doi: 10.1080/10408444.2016.1182116.

4.

HZE Radiation Non-Targeted Effects on the Microenvironment That Mediate Mammary Carcinogenesis.

Barcellos-Hoff MH, Mao JH.

Front Oncol. 2016 Mar 11;6:57. doi: 10.3389/fonc.2016.00057. Review.

5.

Age Effects and Temporal Trends in HPV-Related and HPV-Unrelated Oral Cancer in the United States: A Multistage Carcinogenesis Modeling Analysis.

Brouwer AF, Eisenberg MC, Meza R.

PLoS One. 2016 Mar 10;11(3):e0151098. doi: 10.1371/journal.pone.0151098.

6.

Multistage carcinogenesis and the incidence of thyroid cancer in the US by sex, race, stage and histology.

Meza R, Chang JT.

BMC Public Health. 2015 Aug 18;15:789. doi: 10.1186/s12889-015-2108-4.

7.

Chemical compounds from anthropogenic environment and immune evasion mechanisms: potential interactions.

Kravchenko J, Corsini E, Williams MA, Decker W, Manjili MH, Otsuki T, Singh N, Al-Mulla F, Al-Temaimi R, Amedei A, Colacci AM, Vaccari M, Mondello C, Scovassi AI, Raju J, Hamid RA, Memeo L, Forte S, Roy R, Woodrick J, Salem HK, Ryan EP, Brown DG, Bisson WH, Lowe L, Lyerly HK.

Carcinogenesis. 2015 Jun;36 Suppl 1:S111-27. doi: 10.1093/carcin/bgv033. Review.

8.

Fixation times in differentiation and evolution in the presence of bottlenecks, deserts, and oases.

Chou T, Wang Y.

J Theor Biol. 2015 May 7;372:65-73. doi: 10.1016/j.jtbi.2015.02.021.

9.

Minimizing second cancer risk following radiotherapy: current perspectives.

Ng J, Shuryak I.

Cancer Manag Res. 2014 Dec 17;7:1-11. doi: 10.2147/CMAR.S47220. Review.

10.

Understanding variation in disease risk: the elusive concept of frailty.

Aalen OO, Valberg M, Grotmol T, Tretli S.

Int J Epidemiol. 2015 Aug;44(4):1408-21. doi: 10.1093/ije/dyu192. Review.

11.

Genomic instability and radiation risk in molecular pathways to colon cancer.

Kaiser JC, Meckbach R, Jacob P.

PLoS One. 2014 Oct 30;9(10):e111024. doi: 10.1371/journal.pone.0111024.

12.

Synchrotron-based imaging of chromium and γ-H2AX immunostaining in the duodenum following repeated exposure to Cr(VI) in drinking water.

Thompson CM, Seiter J, Chappell MA, Tappero RV, Proctor DM, Suh M, Wolf JC, Haws LC, Vitale R, Mittal L, Kirman CR, Hays SM, Harris MA.

Toxicol Sci. 2015 Jan;143(1):16-25. doi: 10.1093/toxsci/kfu206.

13.
14.

Altered gene expression patterns during the initiation and promotion stages of neonatally diethylstilbestrol-induced hyperplasia/dysplasia/neoplasia in the hamster uterus.

Hendry WJ, Hariri HY, Alwis ID, Gunewardena SS, Hendry IR.

Reprod Toxicol. 2014 Dec;50:68-86. doi: 10.1016/j.reprotox.2014.09.002.

15.

Cancer stem cells: biological functions and therapeutically targeting.

Ciurea ME, Georgescu AM, Purcaru SO, Artene SA, Emami GH, Boldeanu MV, Tache DE, Dricu A.

Int J Mol Sci. 2014 May 9;15(5):8169-85. doi: 10.3390/ijms15058169. Review.

16.

Modeling Disease Progression with Longitudinal Markers.

Inoue LY, Etzioni R, Morrell C, Müller P.

J Am Stat Assoc. 2008;103(481):259-270.

17.

A population biological approach to understanding the maintenance and loss of the T-cell repertoire during aging.

Johnson PL, Goronzy JJ, Antia R.

Immunology. 2014 Jun;142(2):167-75. doi: 10.1111/imm.12244. Review.

18.

Mathematical models for translational and clinical oncology.

Gallasch R, Efremova M, Charoentong P, Hackl H, Trajanoski Z.

J Clin Bioinforma. 2013 Nov 7;3(1):23. doi: 10.1186/2043-9113-3-23.

19.

Mutator/Hypermutable fetal/juvenile metakaryotic stem cells and human colorectal carcinogenesis.

Kini LG, Herrero-Jimenez P, Kamath T, Sanghvi J, Gutierrez E Jr, Hensle D, Kogel J, Kusko R, Rexer K, Kurzweil R, Refinetti P, Morgenthaler S, Koledova VV, Gostjeva EV, Thilly WG.

Front Oncol. 2013 Oct 29;3:267. doi: 10.3389/fonc.2013.00267. Review.

20.

Advancing human health risk assessment: integrating recent advisory committee recommendations.

Dourson M, Becker RA, Haber LT, Pottenger LH, Bredfeldt T, Fenner-Crisp PA.

Crit Rev Toxicol. 2013 Jul;43(6):467-92. doi: 10.3109/10408444.2013.807223. Review.

Items per page

Supplemental Content

Support Center